Abid Mohiuddin

2.1k citations
15 papers · 857 indexed · h-index 9
Topics
Multiple Myeloma Research and Treatments (14 papers)Protein Degradation and Inhibitors (6 papers)Cancer Treatment and Pharmacology (4 papers)

In The Last Decade

Abid Mohiuddin

14 papers receiving 843 citations

Peers

Abid Mohiuddin
Comparison fields: 5 of 45
  • Hematology 784
  • Molecular Biology 565
  • Oncology 412
  • Genetics 119
  • Radiology, Nuclear Medicine and Imaging 59
Replace Marc Wetterwald with:
Marc Wetterwald France
Mirija Svaldi Italy
Alex Freire Sandes Brazil
Zhengming Jin China
D Samson United Kingdom
Chiara De Philippis Italy
W. Sommerfeld Germany
Georg‐Nikolaus Franke Germany
Santiago Gil Spain
M. J. M. L. Gilmore United Kingdom
Abid Mohiuddin relative to Marc Wetterwald France Marc Wetterwald's profile →
Citations per field
00.5×1.7×
Marc Wetterwald · 1×
Citations per year

Countries citing papers authored by Abid Mohiuddin

Since Specialization
Citations

This map shows the geographic impact of Abid Mohiuddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abid Mohiuddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abid Mohiuddin more than expected).

Fields of papers citing papers by Abid Mohiuddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abid Mohiuddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abid Mohiuddin. The network helps show where Abid Mohiuddin may publish in the future.

Co-authorship network of co-authors of Abid Mohiuddin

This figure shows the co-authorship network connecting the top 25 collaborators of Abid Mohiuddin. A scholar is included among the top collaborators of Abid Mohiuddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abid Mohiuddin. Abid Mohiuddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 10
2 8
3 5
4 0
5 2
6 75
7 38
8 283
9 245
10 46
11 126
12 10
13 1
14 7
15 1

About Abid Mohiuddin

Abid Mohiuddin is a scholar working on Hematology, Oncology and Infectious Diseases, having authored 15 papers that have together received 857 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Hematology (784 citations), Oncology (412 citations) and Genetics (119 citations). Abid Mohiuddin has collaborated with scholars based in United States, Saudi Arabia and Canada. Frequent co-authors include Bart Barlogie, Maurizio Zangari, Elias Anaissie, Mauricio Pineda‐Roman, Klaus Hollmig, Frits van Rhee, John Crowley, Guido Tricot, John D. Shaughnessy and Joshua Epstein. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026